eMedicine Specialties > Neurosurgery > Neoplasm

Intramedullary Spinal Cord Tumors

Author: Alfred T Ogden, MD, Assistant Professor, Department of Neurological Surgery, Columbia University Medical Center
Coauthor(s): Nicholas Wetjen, MD, Pediatric Neurosurgery Fellow, University of Utah, Primary Children's Hospital; Thomas L Francavilla, MD, Chief of Neurosurgery Section, Department of Surgery, Brookwood Medical Center
Contributor Information and Disclosures

Updated: Apr 9, 2009

Introduction

Intramedullary spinal cord tumors refer to a subgroup of intradural spinal tumors that arise from cells within the spinal cord, as opposed to adjacent structures such as the nerve roots or meninges. They are much less common than brain tumors and are thought to account for only 2-4% of all intrinsic tumors of the central nervous system. Their most common initial symptom is generalized back pain, which is very difficult to distinguish clinically from back pain from musculoskeletal conditions.

View of a cervical intramedullary ependymoma in s...

View of a cervical intramedullary ependymoma in situ after midline myelotomy and initial dissection (top left). The tumor was removed en bloc (right), and the postsurgical cavity in the spinal cord is shown (bottom left).

View of a cervical intramedullary ependymoma in s...

View of a cervical intramedullary ependymoma in situ after midline myelotomy and initial dissection (top left). The tumor was removed en bloc (right), and the postsurgical cavity in the spinal cord is shown (bottom left).


Patients are often diagnosed only after the development of neurologic signs and symptoms that may occur later in the course of the disease. Early diagnosis is important, however, because surgical removal for most tumors is curative, and surgical results are optimized when tumors are smaller. Also, neurological deficits resulting from intramedullary spinal cord tumors are seldom reversible. As such, functional outcomes after surgery are closely tied to the patient's preoperative neurologic condition.

History of the Procedure

Important events in the development of our understanding of spinal cord tumors are as follows:

  • In 1887, Horsley performed the first successful removal of an intradural tumor.
  • In 1907, Elsberg performed the first successful removal of an intramedullary tumor and subsequently published the seminal publication on spinal tumors. He developed a two-stage operation in which a myelotomy was performed and the dura was closed in the first stage. In the second stage, the tumor had partially extruded from the spinal cord for easier resection.
  • In 1919, Dandy introduced air-contrast myelography.
  • In 1940, Greenwald introduced bipolar coagulation.
  • In 1964, Kurze introduced the operating microscope.
  • In 1967, Greenwood published a large series detailing successfully removed tumors.
  • In 1990, McCormick published a large surgical series demonstrating excellent long-term outcomes for surgery of ependymomas and established a clinical grading system.

Problem

Intramedullary spinal cord tumors are tumors that occur inside the spinal cord. They are relatively rare, compared with brain tumors, but still affect thousands of patients every year. They are generally slow growing, histologically benign tumors and are often definitely treated with surgery.

Frequency

Spinal tumors occur with an incidence of 1.1 case per 100,000 persons.

Intramedullary spinal tumors comprise approximately 2-4% of all CNS neoplasms.

The most common kinds of intramedullary tumors are ependymomas, astrocytomas, and hemangioblastomas.

In adults, ependymomas are the most common tumor type, accounting for 40-60% of all intramedullary spinal tumors, with the mean age of presentation being 35-40 years.

In children, astrocytomas are the most common tumor type, accounting for around 60% of all intramedullary spinal tumors, and the mean age of presentation is 5-10 years.

Intramedullary spinal tumors can arise anywhere in the spinal cord, from the cervicomedullary junction to the filum terminale, but they are found most frequently in the cervical cord, presumably because it contains more neural tissue than the thoracic or lumbar segments.

Etiology

The etiology of intramedullary spinal tumors remains obscure but undoubtedly varies according to histology. Most intramedullary spinal cord tumors are considered to be glial in origin because they are histologically and immunohistochemically similar to differentiated non-neuronal cell types, such as ependymal cells and astrocytes, which occur in nonpathological spinal cord tissue. The traditional thinking is that tumors occur when these differentiated cells, which normally stop propagating after spinal cord development, acquire mutations that cause them to divide again in an uncontrolled fashion.  

Individuals with type I and type II neurofibromatosis (NF1 and NF2) have been recognized for some time as having an increased incidence of intramedullary spinal tumors, as well many other kinds of tumors, compared with the general population. This general predisposition to tumors has been linked to germline mutations in 2 different genes named for their associated diseases. Patients with the NF1 gene are predisposed to spinal astrocytomas, whereas patients with the NF2 gene are predisposed to spinal ependymomas. Relatively recent genetic analyses of spinal ependymomas from individuals without syndromic neurofibromatosis have shown somatic mutations in the NF2 gene in a subset of cases.

The identification of mitotically active neural stem cells and neural progenitor cells throughout the central nervous system has altered current thinking about how all intrinsic CNS tumors arise. Many lines of evidence point toward neural stem cells as the cells of origin in brain tumors. This line of inquiry is not nearly as advanced in the spinal cord, but some preliminary work has shown similarities between tumor cells from spinal ependymomas and neural stem cells from the spinal cord.

The other relatively common type of intramedullary spinal tumor is hemangioblastoma. Hemangioblastomas are thought to arise from red blood cell precursors and are not intrinsic spinal cord tumors, but they are often anatomically intramedullary because of their association with the blood vessels that penetrate and nourish the spinal cord. Hemangioblastomas occur as a result of mutations in a tumor suppressor gene called vhl, which was found to be altered in patients with the neurocutaneous disorder von Hippel-Lindau disease (VHL). Patients are predisposed to form hemangioblastomas in the brain and spinal cord, and somatic mutations in the in the vhl gene have been found in tumors from patients without syndromic VHL.

Pathophysiology

The pathophysiology of intramedullary spinal cord tumors varies according to tumor type. Ependymomas are usually indolent, encapsulated tumors that are histologically benign. Pain and neurologic deficits arise as a result of a progressive stretching and distortion of nerve fibers. Usually a clear anatomical plane is present at surgery, and a gross visual anatomic resection results in a cure. Rare anaplastic subtypes can be invasive, however, and are more likely to recur or spread through CSF spaces. Even histologically benign–appearing spinal ependymomas can metastasize in this way.

Although malignant forms do exist, most spinal astrocytomas are low grade (WHO grade II) and less aggressive than astrocytomas in the brain. Pain and neurologic defects arise from a combination of nerve fiber stretching and from invasion of cord parenchyma. Because they are infiltrative tumors, complete surgical removal without damage to functional tissue is usually not possible. Exceptions to this general rule may include some pilocytic astrocytomas of the spinal cord (WHO grade I) that are more common in children.

Hemangioblastomas are highly vascular tumors with capillaries that display an increased permeability thought to be related to a hypersensitivity to vascular endothelial growth factor (VEGF). Lesions usually become symptomatic because this capillary hyperpermeability leads to fluid collections or syringes, which are often larger than the tumor itself, causing mass effect in addition to stretching of neural pathways. These fluid spaces are not lined with tumor cells, however, and only the tumor nidus needs to be removed at surgery.

Presentation

Symptoms

The clinical features of intramedullary spinal cord tumors are variable. Symptoms are not specific to spinal cord tumors and may be present in any myelopathic process.

Because of the slow-growing nature of many of these tumors, symptoms precede diagnosis an average of 2 years. Patients with malignant or metastatic spinal cord tumors present in the range of several weeks to a few months after symptoms develop.

Pain and weakness are the most common presenting symptoms of intramedullary spinal cord tumors. Pain is often the earliest symptom, classically occurring at night when the patient is supine. The pain is typically local over the level of the tumor but may radiate.

Progressive weakness may occur in the arms (cervical tumors) or legs (cervical, thoracic, conus tumors). Impaired bowel, bladder, or sexual function often occurs early. Patients may have poor balance. Rarely, symptoms of subarachnoid hemorrhage may be present.

Intratumoral hemorrhage can cause an abrupt deterioration, a presentation most often associated with ependymomas.

Examination

Examination may reveal a combination of upper and lower motor neuron signs. Lower motor signs may be at the level of the lesion and may aid in localization. Other signs evident upon physical examination may include spine tenderness, stiffening of gait, trophic changes of extremity, sensory loss, hyperreflexia, clonus, and scoliosis or torticollis (generally in children).

Indications

The first-line treatment for intramedullary tumors is open surgical resection. Surgery is indicated for all symptomatic lesions. Small asymptomatic lesions may be followed clinically and radiographically because the majority of intramedullary tumors are relatively benign and slow growing. However, this approach carries the risk of the development of neurological deficits that are likely not recoverable and the uncertainty that comes with undetermined diagnosis.  

At surgery, aggressiveness with respect to resection depends on the histological diagnosis of a frozen section and the ability to find and maintain a surgical plane. Given the difficulty in determining many ependymomas from astrocytomas on frozen section, the presence or absence of a clear surgical plane is usually the key determining factor in defining the surgical goal. If, after analysis of all available data including imaging characteristics, frozen section, and intraoperative appearance, a diagnosis of ependymoma is perceived, a complete surgical resection should be attempted. If a diagnosis of astrocytoma is perceived, most clinicians advocate a more limited debulking of only the tissue that is clearly abnormal. 

External beam radiation is generally reserved for disseminated ependymomas and infiltrative astrocytomas but remains an option whenever radiographic residual or recurrent ependymoma is found. Stereotactic radiosurgery for intramedullary tumors remains untested.

Relevant Anatomy

The spinal cord originates at the foramen magnum and extends to the conus medullaris, which terminates at the L1-L2 vertebral body junction in adults. The pia matter condenses caudally to this area, extending to the sacrum as the filum terminale. It is an ovoid structure, most narrow in the anterior-posterior direction. At every vertebral level paired ventral and dorsal nerve roots exit the lateral aspect of the cord and coalesce to form 31 pairs of spinal nerves.  

In contrast to the brain, the white matter of the spinal cord surrounds the interior gray matter. The spinal cord is covered by a supporting connective tissue layer called the pia matter that acts as a trellis for the vascular supply. A vestigial extension of the ventricular system, the central canal runs the length of the spinal cord. Dilation of the central canal may be pathologic in some instances. In general, ventral portion of the spinal cord parenchyma subserves motor function, whereas the dorsal portion subserves sensation. The spinal cord contains the same cell types as the brain, but these are highly specialized to their niche in the spinal cord.  

The vascular supply for the spinal cord comes from the anterior spinal artery, the paired posterior spinal arteries, and the 31 radicular arteries. The anterior and posterior spinal arteries form off branches of the vertebral arteries at the cervicomedullary junction and course inferiorly along the length of the spinal cord. The anterior spinal artery is relatively constant and runs in the middle of the ventral surface of the cord, sending deep penetrating branches into the anterior median sulcus. These branches then send arterial twigs radially to the deepest portions of the spinal cord.

The paired posterior spinal arteries are relatively inconstant, course along the posterolateral surface of the cord, medial to the dorsal root entry zones, and send short penetrating end arterioles into the dorsal cord parenchyma. Thus, the anterior spinal artery supplies the ventral two thirds of the cord, whereas the posterior spinal artery supplies the dorsal third.

The spinal arteries form the nexus of an arterial network that is replenished by the radicular arteries that enter the spinal canal through the spinal nerve root sleeves. The radicular supply to the spinal cord is highly variable, but a few vital feeding arteries are usually present. The most important of these is the artery of Adamkiewicz, which is usually found on the left side, from T9 to L2.

Contraindications

Absolute contraindications to surgical intervention include uncorrected coagulopathy and systemic infection.

Relative contraindications to surgical intervention include complete neurologic deficit over 24 hours and short life expectancy.

More on Intramedullary Spinal Cord Tumors

Overview: Intramedullary Spinal Cord Tumors
Workup: Intramedullary Spinal Cord Tumors
Treatment: Intramedullary Spinal Cord Tumors
Follow-up: Intramedullary Spinal Cord Tumors
Multimedia: Intramedullary Spinal Cord Tumors
References

References

  1. Lee M, Rezai AR, Abbott R, et al. Intramedullary spinal cord lipomas. J Neurosurg. Mar 1995;82(3):394-400. [Medline].

  2. Kothbauer K, Deletis V, Epstein FJ. Intraoperative spinal cord monitoring for intramedullary surgery: an essential adjunct. Pediatr Neurosurg. May 1997;26(5):247-54. [Medline].

  3. Cristante L, Herrmann HD. Surgical management of intramedullary spinal cord tumors: functional outcome and sources of morbidity. Neurosurgery. Jul 1994;35(1):69-74; discussion 74-6. [Medline].

  4. Sgouros S, Malluci CL, Jackowski A. Spinal ependymomas--the value of postoperative radiotherapy for residual disease control. Br J Neurosurg. Dec 1996;10(6):559-66. [Medline].

  5. Jyothirmayi R, Madhavan J, Nair MK, et al. Conservative surgery and radiotherapy in the treatment of spinal cord astrocytoma. J Neurooncol. Jul 1997;33(3):205-11. [Medline].

  6. Epstein FJ, Farmer JP, Freed D. Adult intramedullary astrocytomas of the spinal cord. J Neurosurg. Sep 1992;77(3):355-9. [Medline].

  7. Epstein FJ, Farmer JP, Freed D. Adult intramedullary spinal cord ependymomas: the result of surgery in 38 patients. J Neurosurg. Aug 1993;79(2):204-9. [Medline].

  8. Greenwood J Jr. Surgical removal of intramedullary tumors. J Neurosurg. Feb 1967;26(2):276-82. [Medline].

  9. Hoshimaru M, Koyama T, Hashimoto N, et al. Results of microsurgical treatment for intramedullary spinal cord ependymomas: analysis of 36 cases. Neurosurgery. Feb 1999;44(2):264-9. [Medline].

  10. Lee M, Epstein FJ, Rezai AR, et al. Nonneoplastic intramedullary spinal cord lesions mimicking tumors. Neurosurgery. Oct 1998;43(4):788-94; discussion 794-5. [Medline].

  11. Malis LI. Intramedullary spinal cord tumors. Clin Neurosurg. 1978;25:512-39. [Medline].

  12. McCormick PC, Torres R, Post KD, et al. Intramedullary ependymoma of the spinal cord. J Neurosurg. Apr 1990;72(4):523-32. [Medline].

  13. Ogden, AT and McCormick, PC. Intradural Spinal Tumors. In: Bernstein, M and Berger, MS. Neuro-oncology: The Essentials. 2. New York: Thieme; 2008:36: 379-390.

  14. Sandler HM, Papadopoulos SM, Thornton AF Jr, et al. Spinal cord astrocytomas: results of therapy. Neurosurgery. Apr 1992;30(4):490-3. [Medline].

  15. Stein BM, McCormick PC. Intramedullary neoplasms and vascular malformations. Clin Neurosurg. 1992;39:361-87. [Medline].

  16. Stein BM, McCormick PC. Spinal intradural tumors. In: Wilkins RH, Rengachary SS, eds. Neurosurgery. New York, NY: McGraw-Hill; 1996:1769-89.

Further Reading

Keywords

spinal cord, intramedullary spinal tumors, intramedullary spinal cord tumor, intrinsic spinal tumors, intrinsic spinal tumor, spinal cord tumors, spinal cord tumor, intramedullary tumors, intramedullary tumor, intradural spinal tumors, intradural spinal tumor, intramedullary, spinal cord, tumors, tumor, spine tumors, spine tumor, spinal tumors, spinal tumor, spinal 

Contributor Information and Disclosures

Author

Alfred T Ogden, MD, Assistant Professor, Department of Neurological Surgery, Columbia University Medical Center
Alfred T Ogden, MD is a member of the following medical societies: Alpha Omega Alpha, American Association of Neurological Surgeons, and Congress of Neurological Surgeons
Disclosure: Nothing to disclose.

Coauthor(s)

Nicholas Wetjen, MD, Pediatric Neurosurgery Fellow, University of Utah, Primary Children's Hospital
Nicholas Wetjen, MD is a member of the following medical societies: American Association of Neurological Surgeons and Congress of Neurological Surgeons
Disclosure: Nothing to disclose.

Thomas L Francavilla, MD, Chief of Neurosurgery Section, Department of Surgery, Brookwood Medical Center
Thomas L Francavilla, MD is a member of the following medical societies: American Association of Neurological Surgeons and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Duc Hoang Duong, MD, Professor, Chief Physician, Departments of Neurological Surgery and Neuroscience, Epilepsy Center, Charles R Drew University
Duc Hoang Duong, MD is a member of the following medical societies: American Neurological Association, Congress of Neurological Surgeons, and North American Skull Base Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Ryszard M Pluta, MD, PhD, Associate Professor, Neurosurgical Department Medical Research Center, Polish Academy of Sciences at Warsaw, Poland; Senior Researcher, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH
Ryszard M Pluta, MD, PhD is a member of the following medical societies: Congress of Neurological Surgeons and Polish Society of Neurosurgeons
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

Allen R Wyler, MD, Former Medical Director, Northstar Neuroscience, Inc
Allen R Wyler, MD is a member of the following medical societies: American Academy of Neurological and Orthopaedic Surgeons, American Association of Neurological Surgeons, and Society of Neurological Surgeons
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.